Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinic acid prolonged-release add-on to statin therapy in type 2 diabetes with endothelial dysfunction
ACTRN12606000466549Phase 4Completed
- Sponsor
- Professor Gerald Watts
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of niacin in type 2 diabetes mellitus (T2DM) and lipid disorder (2 arms), sponsored by Professor Gerald Watts. Primary endpoint: Change in brachial artery flow-mediated dilatation. Started Nov 2006; status: completed.
02
Drugs
niacin
03
Conditions
type 2 diabetes mellitus (T2DM)lipid disorder
Beyond the preview
Go deeper on ACTRN12606000466549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000466549.